Julie Jordan
Chief Medical Officer, Q32 Bio Inc.
Companies
- Neurogene Inc.Chief Medical Officer Jan 18, 2024 to now1
- Q32 Bio Inc.Chief Medical Officer Mar 16, 2023 to Aug 7, 20232
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Neurogene Inc. NGNE12,472 shares3$298.0K at $23.89Mar 26, 2026
- Q32 Bio Inc. QTTB7,496 shares4$58.5K at $7.81Aug 3, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 26, 2026Sold 828 shares at $21.89 of Neurogene Inc.3
- Feb 20, 2026Granted 4,900 shares of Neurogene Inc.5
- Mar 26, 2025Granted 8,400 shares of Neurogene Inc.6
- Aug 3, 2023Sold 1,308 shares at $1.39 of Q32 Bio Inc.4
- Aug 3, 2023Exercised options 4,644 shares of Q32 Bio Inc.4
- Aug 3, 2023Sold 109 shares at $1.39 of Q32 Bio Inc.4
- Aug 3, 2023Exercised options 387 shares of Q32 Bio Inc.4
- Aug 3, 2023Sold 436 shares at $1.39 of Q32 Bio Inc.4
- Aug 3, 2023Exercised options 1,548 shares of Q32 Bio Inc.4
- Aug 2, 2023Sold 99 shares at $1.31 of Q32 Bio Inc.7
- Aug 2, 2023Exercised options 350 shares of Q32 Bio Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARQ32 Bio Inc., Chief Medical Officer
- 3
- 4
- 5SEC EDGARForm 4 filed Feb 24, 2026
- 6SEC EDGARForm 4 filed Mar 28, 2025
- 7SEC EDGARForm 4 filed Aug 4, 2023